Active, not recruitingPhase 2NCT06007677
A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema
Studying Hereditary angioedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Astria Therapeutics, Inc.
- Intervention
- STAR-0215(drug)
- Enrollment
- 56 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2031
Study locations (22)
- Allervie Clinical Research, Birmingham, Alabama, United States
- Medical Research of Arizona a Division of Allergy, Asthma & Immunology Associates, LTD, Scottsdale, Arizona, United States
- Acuro Research, Little Rock, Arkansas, United States
- UC San Diego US HAEA Angioedema Center, San Diego, California, United States
- Raffi Tachdjian MD, Inc, Santa Monica, California, United States
- Allergy & Asthma Clinical Research, Walnut Creek, California, United States
- Institute for Asthma and Allergy, PC, Chevy Chase, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Optimed Research, Columbus, Ohio, United States
- Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
- AARA Research Center, Dallas, Texas, United States
- Diagnostic Consultative Center Convex Ltd., Sofia, Bulgaria
- University of Alberta, Edmonton, Alberta, Canada
- Ottawa Allergy Research Corporation, Ottawa, Ontario, Canada
- +7 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06007677 on ClinicalTrials.govOther trials for Hereditary angioedema
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07298447Donidalorsen Treatment in Children With Hereditary AngioedemaIonis Pharmaceuticals, Inc.
- RECRUITINGNANCT07559630Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidSJessica K. Stewart, MD
- RECRUITINGPHASE3NCT07428499Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)ADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07251933A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple CountriesTakeda
- ENROLLING BY INVITATIONPHASE3NCT07204938A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPHASE3NCT06960213STOP-HAE: A Phase 3 Study of ADX-324 in HAEADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)CSL Behring
- RECRUITINGPHASE3NCT06842823A Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.